New allergy vaccine works in a matter of weeks
Researchers at the Swiss Institute of Allergy and Asthma Research say they've developed a vaccine that delivers antigens directly into immune cells. The work could revolutionize allergy treatments, replacing years of injections with a new approach that could work in a matter of weeks. The antigens trigger an immune response, building the body's ability to ward off an allergy. Because antigens are delivered precisely, the new approach also dramatically reduces the amount of vaccine required for a therapeutic effect. The technology requires a molecule that includes a translocation unit, a targeting unit along with an allergen.
- read the report from New Scientist
Related Articles:
Vaccine list grows more expensive. Report
Teen vaccine market poised for growth. Report
Vaccine development surges. Report
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

